Clinical trial · Observational
Quality of Life After Permanent Interstitial Iodine Seed Prostate Brachytherapy
Retrospective Analysis of Quality of Life After Permanent Interstitial Iodine Seed Brachytherapy for Prostate Cancer
NCT02652000CI-TRIAL-00025127completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Retrospective study to analyze Quality of life in men after iodine seed brachytherapy for localized prostate cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasms, Prostate | Prostate Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No intervention in this retrospective study | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- CTCAE v4.03ff Grade 1-4 Sexual/Reproductive Function
- timeFrame
- 5 years (2009-2014)
- description
- Scale
Secondary outcomes (4)
- measure
- CTCAE v4.03ff Grade 1-4 Gastrointestinal
- timeFrame
- 5 years (2009-2014)
- description
- Scale
- measure
- CTCAE v4.03ff Grade 1-4 Renal/Genitourinary
- timeFrame
- 5 years (2009-2014)
- description
- Scale
- measure
- International Prostate Symptom Score (IPSS)
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 48 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Male \> 18 years of age * iodine seed brachytherapy for localized prostate cancer at the University Hospital Zurich Exclusion Criteria: * No iodine seed brachytherapy for localized prostate cancer at the University Hospital Zurich
References
Publications (0)
Data not yet available
No reference posted for this study.